EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effects of 0.024% latanoprostene bunod on intraocular pressure and pupil diameter in normal cats and cats with congenital glaucoma

Vanessa Y Yang iD, J Seth Eaton iD, Julie A Kiland iD, Kelly E Koch, Kazuya Oikawa iD, Scott J Hetzel, Gillian J McLellan

Veterinary Ophthalmology · 2026

DOI: 10.1111/vop.13302 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Ophthalmology, 2026. Verfasst von Vanessa Y Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin - Madison, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Intraocular Pressure, Cat Diseases, Latanoprost, Glaucoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS, Vision for Animals Foundation (VAF) Resident Grant, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the effects of latanoprostene bunod on intraocular pressure (IOP) and pupil diameter (PD) in normal cats and cats with feline congenital glaucoma (FCG). Animals Studied Five normal and 5 FCG cats. Procedures This masked, controlled crossover study comprised a 1‐day Pre‐treatment phase followed by two 10‐day Treatment phases, each followed by a 10‐day Recovery phase. During treatment, all cats received twice daily 0.005% latanoprost (LAT) or 0.024% latanoprostene bunod (LBN) in a randomized eye. Following Recovery, the same eye was treated with the opposite drug. Contralateral eyes served as saline‐treated controls. Intraocular pressure and PD measurements were performed three times daily during all study phases. Data were analyzed via constrained longitudinal data analysis models.

Results

Neither drug significantly reduced IOP in normal cats. In FCG cats, statistically significant reductions in mean (95% CI) IOP were observed relative to controls 4 h after LAT and LBN treatment (−5.5 mmHg [−8.4, −2.5], p < .001, −7.2 mmHg [−10.2, −4.3], p < .001, respectively). These differences represented 28.4% and 37.9% IOP reductions, respectively. Mean IOP reduction after 4 h was significantly greater with LBN treatment compared to LAT (−1.8 mmHg [−3.2, −0.4], p = .012). However, these IOP reductions were not considered clinically significant. Both drugs similarly reduced PD in normal and FCG cats.

Conclusions

Transient IOP reduction was observed after topical administration of LAT and LBN in FCG cats; and mean IOP difference was statistically significantly greater in LBN‐treated eyes. However, the apparent enhanced hypotensive effect of LBN is not clinically significant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intraocular PressureCat DiseasesLatanoprostGlaucomaPupilProstaglandins F, SyntheticAntihypertensive AgentsAnimalsCatsCross-Over StudiesFemaleMaleOphthalmic Solutions

Stichwörter der Autor:innen

catglaucomaintraocular pressurelatanoprostlatanoprostene bunodpupil diameter

Substanzen

LatanoprostProstaglandins F, SyntheticOphthalmic SolutionsAntihypertensive AgentsBOL 303259-X

Autor:innen und Institutionen

  • Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin - Madison, Madison, Wisconsin, USA.
  • Department of Ophthalmology and Visual Sciences, School of Medicine and Public Health, University of Wisconsin - Madison, Madison, Wisconsin, USA.
  • Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin - Madison, Madison, Wisconsin, USA.

ORCID-Profile: Vanessa Y Yang, J Seth Eaton, Julie A Kiland, Kazuya Oikawa

Förderung

  • NEI NIH HHS
  • Vision for Animals Foundation (VAF) Resident Grant
  • NCATS NIH HHS
  • University of Wisconsin - Madison School of Veterinary Medicine Companion Animal Fund (CAF)
  • American College of Veterinary Ophthalmologists Vision for Animals Foundation

Zitieren

APA

Yang, V. Y., Eaton, J. S., Kiland, J. A., Koch, K. E., Oikawa, K., Hetzel, S. J., & McLellan, G. J. (2026). Effects of 0.024% latanoprostene bunod on intraocular pressure and pupil diameter in normal cats and cats with congenital glaucoma. Veterinary Ophthalmology. https://doi.org/10.1111/vop.13302

Vancouver

Yang VY, Eaton JS, Kiland JA, Koch KE, Oikawa K, Hetzel SJ, et al. Effects of 0.024% latanoprostene bunod on intraocular pressure and pupil diameter in normal cats and cats with congenital glaucoma. Veterinary Ophthalmology. 2026. doi:10.1111/vop.13302

BibTeX
@article{Yang2026,
  author = {Yang, Vanessa Y and Eaton, J Seth and Kiland, Julie A and Koch, Kelly E and Oikawa, Kazuya and Hetzel, Scott J and McLellan, Gillian J},
  title = {Effects of 0.024% latanoprostene bunod on intraocular pressure and pupil diameter in normal cats and cats with congenital glaucoma},
  journal = {Veterinary Ophthalmology},
  year = {2026},
  doi = {10.1111/vop.13302}
}
Kostenlos starten →